Indee Labs

Indee Labs

Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.

Edit ID  5393308 

Ryan Pawell"update total fundraise amount"
Ryan Pawell edited on 14 Aug, 2018
Edits made to:
Article (+3/-3 characters)

As of May 2018, Indee Labs had accumulated more than USD$5.45.6 million dollars in angel, venture and non-dilutive capital.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.